4.8 Article

Runx3 is required for oncogenic Myc upregulation in p53-deficient osteosarcoma

期刊

ONCOGENE
卷 41, 期 5, 页码 683-691

出版社

SPRINGERNATURE
DOI: 10.1038/s41388-021-02120-w

关键词

-

资金

  1. KAKENHI/Japan Society for the Promotion of Science (JSPS) [26290040, 18H02972, 19K22724]
  2. JSPS Research Fellowship for Young Scientists [18J20543]
  3. Funding Program for Next Generation World-Leading Researchers [LS097]
  4. Grants-in-Aid for Scientific Research [19K22724, 18J20543, 26290040, 18H02972] Funding Source: KAKEN

向作者/读者索取更多资源

This study found that the deficiency of p53 promotes osteosarcomagenesis in both human and mouse by allowing Runx3 to induce oncogenic Myc expression. Reduction of Myc levels by disrupting mR1 or knocking down Runx3 can decrease tumorigenicity in p53-deficient OS cells and effectively suppress OS development in OS mice. Furthermore, Runx inhibitors have therapeutic effects on OS mice.
Osteosarcoma (OS) in human patients is characterized by genetic alteration of TP53. Osteoprogenitor-specific p53-deleted mice (OS mice) have been widely used to study the process of osteosarcomagenesis. However, the molecular mechanisms responsible for the development of OS upon p53 inactivation remain largely unknown. In this study, we detected prominent RUNX3/Runx3 expression in human and mouse p53-deficient OS. Myc was aberrantly upregulated by Runx3 via mR1, a consensus Runx site in the Myc promoter, in a manner dependent on p53 deficiency. Reduction of the Myc level by disruption of mR1 or Runx3 knockdown decreased the tumorigenicity of p53-deficient OS cells and effectively suppressed OS development in OS mice. Furthermore, Runx inhibitors exerted therapeutic effects on OS mice. Together, these results show that p53 deficiency promotes osteosarcomagenesis in human and mouse by allowing Runx3 to induce oncogenic Myc expression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据